We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BON
4026
Bon Natural Life
BON
$9.35M
$12K ﹤0.01%
+44
New +$14.7K
FRSX
4027
Foresight Autonomous Holdings
FRSX
$3.93M
$12K ﹤0.01%
228
-1,357
-86% -$96.5K
ALLR
4028
Allarity Therapeutics
ALLR
$21.6M
– –
0
– –
CRBP icon
4029
Corbus Pharmaceuticals
CRBP
$195M
$11K ﹤0.01%
3,423
-22,928
-87% -$88.2K
XMAX
4030
XMAX Inc
XMAX
$565M
$11K ﹤0.01%
4,849
-240
-5% -$684
SOPA
4031
DELISTED
Society Pass
SOPA
$11K ﹤0.01%
+760
New +$16.6K
VTGN icon
4032
VistaGen Therapeutics
VTGN
$11.8M
$11K ﹤0.01%
3,493
-121,919
-97% -$459K
EGLX
4033
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$11K ﹤0.01%
+19,600
New +$13K
ACGN
4034
DELISTED
Aceragen Inc
ACGN
$11K ﹤0.01%
1,865
+22
+1% +$132
REED
4035
DELISTED
Reeds, Inc. Common Stock
REED
$11K ﹤0.01%
3,196
+310
+11% +$1.74K
PRFX icon
4036
PRF Technologies Ltd
PRFX
$3.65M
$10K ﹤0.01%
20
-1
-5% -$636
CNTN
4037
Canton Strategic Holdings
CNTN
$152M
$10K ﹤0.01%
+70
New +$13.9K
BLCM
4038
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$10K ﹤0.01%
13,700
– –
VYNT
4039
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$10K ﹤0.01%
14,320
+10,160
+244% +$16.5K
IMDX
4040
Insight Molecular Diagnostics
IMDX
$121M
$9K ﹤0.01%
+1,410
New +$15.5K
RNAZ icon
4041
TransCode Therapeutics
RNAZ
$3.68M
– –
0
– –
PLXP
4042
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$9K ﹤0.01%
+54,500
New +$22.8K
ASPU
4043
DELISTED
ASPEN GROUP, INC.
ASPU
$9K ﹤0.01%
27,600
-12,450
-31% -$4.51K
CUEN
4044
DELISTED
Cuentas Inc. Common Stock
CUEN
$9K ﹤0.01%
+4,015
New +$17.1K
HSTO
4045
DELISTED
Histogen Inc. Common Stock
HSTO
$9K ﹤0.01%
+10,600
New +$11.8K
VRAX icon
4046
Virax Biolabs
VRAX
$2.25M
$8K ﹤0.01%
+46
New +$16.3K
LKCO
4047
DELISTED
Luokung Technology Corp Ordinary Shares
LKCO
$8K ﹤0.01%
208
+28
+16% +$1.17K
AWH
4048
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$8K ﹤0.01%
1,700
-174
-9% -$951
VISL
4049
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$8K ﹤0.01%
+720
New +$5.91K
EFOI icon
4050
Energy Focus
EFOI
$19.1M
$7K ﹤0.01%
3,171
-10,720
-77% -$29.4K
160 161
162
163 164

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q4 2022 Portfolio in Review

As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
  • Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Jim Simons opened 626 new positions and closed 524 in Q4 2022.
  • Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.